HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin H Prins Selected Research

idraparinux

7/2010Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
9/2007Idraparinux versus standard therapy for venous thromboembolic disease.
9/2007Extended prophylaxis of venous thromboembolism with idraparinux.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin H Prins Research Topics

Disease

59Venous Thromboembolism
01/2022 - 03/2002
47Hemorrhage
01/2022 - 11/2002
42Venous Thrombosis (Deep-Vein Thrombosis)
12/2020 - 04/2002
26Pulmonary Embolism
10/2018 - 06/2003
16Thrombosis (Thrombus)
01/2022 - 04/2002
14Neoplasms (Cancer)
10/2018 - 09/2002
9Intermittent Claudication
08/2013 - 06/2007
7Thromboembolism
12/2018 - 12/2003
7Cardiovascular Diseases (Cardiovascular Disease)
12/2018 - 10/2006
5Body Weight (Weight, Body)
10/2018 - 06/2004
5Peripheral Arterial Disease
08/2013 - 07/2002
4Atherosclerosis
02/2015 - 07/2002
4Infections
02/2015 - 05/2005
4Atrial Fibrillation
06/2014 - 12/2006
4Stroke (Strokes)
04/2014 - 11/2005
4Ocular Hypertension (Glaucoma, Suspect)
03/2012 - 07/2005
4Inflammation (Inflammations)
02/2012 - 03/2006
4Thrombophilia
04/2010 - 04/2003
4Hyperhomocysteinemia
07/2008 - 10/2004
3Chronic Obstructive Pulmonary Disease (COPD)
08/2012 - 10/2009
3Abdominal Aortic Aneurysm
04/2012 - 05/2010
3Glaucoma
03/2012 - 02/2010
3Postthrombotic Syndrome
02/2012 - 09/2004
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2012 - 08/2010
3Myocardial Infarction
06/2006 - 07/2002
2Frailty
01/2022 - 10/2018
2Hypertension (High Blood Pressure)
05/2012 - 02/2006
2Heart Failure
05/2012 - 10/2009
2Coronary Artery Disease (Coronary Atherosclerosis)
05/2012 - 06/2003
2Blindness (Hysterical Blindness)
03/2012 - 01/2011
2Diabetic Nephropathies (Diabetic Nephropathy)
02/2011 - 08/2010
2Ischemic Stroke
06/2010 - 07/2002
2Open-Angle Glaucoma (Glaucoma, Open Angle)
02/2010 - 07/2005
2Protein S Deficiency (Deficiency, Protein S)
05/2009 - 03/2005
1Menorrhagia
02/2021
1Venous Insufficiency
01/2018
1Calculi (Calculus)
10/2017
1Uterine Hemorrhage (Uterine Bleeding)
03/2016
1Embolism (Embolus)
12/2014

Drug/Important Bio-Agent (IBA)

33RivaroxabanIBA
01/2022 - 09/2008
31AnticoagulantsIBA
02/2021 - 03/2002
28Vitamin KFDA Link
01/2022 - 06/2003
15Enoxaparin (Lovenox)FDA LinkGeneric
01/2022 - 06/2004
12Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2019 - 06/2004
11Heparin (Liquaemin)FDA LinkGeneric
01/2020 - 06/2004
9fibrin fragment D (D-dimer)IBA
01/2019 - 04/2002
9Prothrombin (Factor II)IBA
04/2011 - 07/2002
7Warfarin (Coumadin)FDA LinkGeneric
01/2015 - 07/2003
7factor V LeidenIBA
04/2011 - 03/2002
7Factor VIII (Coagulation Factor VIII)IBA
08/2008 - 10/2002
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2021 - 04/2014
6Factor Xa InhibitorsIBA
02/2015 - 09/2008
6Pharmaceutical PreparationsIBA
10/2014 - 06/2007
4Fondaparinux (Arixtra)FDA Link
10/2019 - 06/2004
4hydroxide ionIBA
03/2012 - 07/2005
4Protein SIBA
08/2011 - 03/2005
3CreatinineIBA
12/2013 - 08/2012
3LipidsIBA
05/2013 - 07/2010
3AntithrombinsIBA
08/2011 - 07/2008
3Protein CIBA
08/2011 - 07/2008
3idraparinuxIBA
07/2010 - 09/2007
2Cytochrome P-450 CYP3AIBA
01/2022 - 10/2018
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2022 - 10/2018
2Proteins (Proteins, Gene)FDA Link
12/2018 - 10/2002
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
02/2015 - 10/2008
2Biological ProductsIBA
02/2014 - 11/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2014 - 07/2010
2Timolol (Blocadren)FDA LinkGeneric
03/2012 - 01/2011
2Latanoprost (Xalatan)FDA Link
03/2012 - 01/2011
2Biomarkers (Surrogate Marker)IBA
02/2011 - 08/2010
2Advanced Glycation End ProductsIBA
02/2011 - 08/2010
2Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
07/2008 - 10/2002
2HomocysteineIBA
08/2007 - 10/2004
1SuspensionsIBA
01/2020
1TabletsIBA
01/2020
1CollagenIBA
12/2018
1Apolipoproteins E (ApoE)IBA
12/2018
1boldenone undecylenate (Equipoise)IBA
01/2017
1apixabanIBA
01/2017
1Hormones (Hormone)IBA
03/2016
1Estrogens (Estrogen)FDA Link
03/2016
1Hemoglobins (Hemoglobin)IBA
02/2016
1Clopidogrel (Plavix)FDA Link
02/2015
1AcenocoumarolIBA
10/2014

Therapy/Procedure

47Therapeutics
02/2021 - 11/2002
9Exercise Therapy (Therapy, Exercise)
08/2013 - 06/2007
8Compression Stockings
01/2022 - 08/2004
5Catheters
10/2020 - 12/2006
4Duration of Therapy
01/2018 - 07/2003
3Endovascular Aneurysm Repair
04/2012 - 05/2010
2Central Venous Catheters
10/2020 - 01/2004
2Secondary Prevention
07/2017 - 02/2015
2Blood Transfusion (Blood Transfusions)
02/2016 - 05/2005
2Surgical Amputation (Amputations)
02/2015 - 06/2007
2Hip Replacement Arthroplasty (Total Hip Replacement)
02/2014 - 09/2007
2Electric Countershock (Cardioversion)
05/2012 - 12/2006
2Length of Stay
06/2010 - 06/2006
2Aftercare (After-Treatment)
12/2003 - 06/2003
1Polypharmacy
01/2022
1Ligation
12/2018